Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara) announced that the Company decided partial changes of the planned position of Corporate Officers at its Board of Directors Meeting held today, regarding the announcement on Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers made on April 5, 2021.
　The appointments for candidates of Members of the Board of Directors and Audit & Supervisory Board Members will be resolved at the 73rd Annual Shareholders Meeting scheduled for June 17, 2021. The changes and appointments of Members of the Board of Directors, Standing Audit & Supervisory Board Members and Corporate Officers will be officially decided at the Board of Directors Meeting and Audit & Supervisory Board Meeting to be held on the same day after the Annual Shareholders Meeting.

1. Changes of the position of Corporate Officers (scheduled for June 17, 2021)

   Name	After	Before
   Toshihiro Tsujinaka	Member of the Board of Directors, Senior Executive Officer	Member of the Board of Directors, Executive Officer
   Toichi Takino	Member of the Board of Directors, Senior Executive Officer	Member of the Board of Directors, Executive Officer

2. The followings are the appointments of Members of the Board of Directors, Audit & Supervisory Board Members, and Corporate Officers (scheduled for June 17, 2021).
   *: Candidates of Members of the Board of Directors and Audit & Supervisory Board Members for subject to approval at the 73rd Annual Shareholders Meeting

   Members of the Board of Directors：
   - Gyo Sagara*　　President, Representative Director
   - Toshihiro Tsujinaka*　　Senior Executive Officer, Executive Director, Corporate Strategy & Planning
   - Toichi Takino*　　Senior Executive Officer, Executive Director, Discovery & Research
   - Isao Ono*　　Executive Officer, Director, Corporate Research
   - Kiyoaki Idemitsu*　　Executive Director, Clinical Development
   - Masao Nomura*　　Outside Member of the Board of Director
   - Akiko Okuno*　　Outside Member of the Board of Director
   - Shusaku Nagae*　　Outside Member of the Board of Director

   Audit & Supervisory Board Members：
   - Katsuyoshi Nishimura　　 Audit & Supervisory Board Member (full-time)
   - Hironobu Tanisaka*　　 Audit & Supervisory Board Member (full-time)
   - Yasuo Hishiyama 　　Outside Audit & Supervisory Board Member
   - Akiko Tanabe　　 Outside Audit & Supervisory Board Member

   Corporate Officers：
   - Hiroshi Ichikawa　　 Corporate Senior Executive Officer, Executive Director, Sales and Marketing
   - Yukio Tani　　 Corporate Executive Officer, Head of Corporate Communications
   - Shozo Matsuoka　　 Corporate Executive Officer, Executive Director, Corporate Regulatory Compliance, Safety and Quality Assurance
   - Katsuji Teranishi　　 Corporate Officer, Division Director, Sales Division, Western Japan Region
   - Hiromu Habashita　　 Corporate Officer, Deputy Executive Director, Discovery & Research
   - Shinji Takai　　 Corporate Officer, Head of Medical Affairs / Head of Data Strategy
   - Keiji Masui　　 Corporate Officer, Division Director, Sales Division, Eastern Japan Region
   - Masaki Ito　　 Corporate Officer, Director, Corporate Planning Department